Unfolding the role of calreticulin in myeloproliferative neoplasm pathogenesis Review


Authors: Merlinsky, T. R.; Levine, R. L.; Pronier, E.
Review Title: Unfolding the role of calreticulin in myeloproliferative neoplasm pathogenesis
Abstract: In 2013, two seminal studies identified gain-of-function mutations in the Calreticulin (CALR) gene in a subset of JAK2/MPL-negative myeloproliferative neoplasm (MPN) patients. CALR is an endoplasmic reticulum (ER) chaperone protein that normally binds misfolded proteins in the ER and prevents their export to the Golgi and had never previously been reported mutated in cancer or to be associated with hematologic disorders. Further investigation determined that mutated CALR is able to achieve oncogenic transformation primarily through constitutive activation of the MPL–JAK–STAT signaling axis. Here we review our current understanding of the role of CALR mutations in MPN pathogenesis and how these insights can lead to innovative therapeutics approaches. © 2019 American Association for Cancer Research.
Journal Title: Clinical Cancer Research
Volume: 25
Issue: 10
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2019-05-15
Start Page: 2956
End Page: 2962
Language: English
DOI: 10.1158/1078-0432.Ccr-18-3777
PROVIDER: scopus
PMCID: PMC6522317
PUBMED: 30655313
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    776 Levine
  2. Elodie Pronier
    10 Pronier